Σεπ162015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα16 Σεπτεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:EASL Clinical Practice Guidelines: Autoimmune hepatitisΕπόμενοNext post:Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Σχετικά ΆρθραUsing liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol- related liver disease19 Μαρτίου 2024Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC12 Μαρτίου 2024Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial5 Μαρτίου 2024A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis3 Μαρτίου 2024A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis26 Φεβρουαρίου 2024Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria2 Φεβρουαρίου 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol- related liver disease19 Μαρτίου 2024
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC12 Μαρτίου 2024
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial5 Μαρτίου 2024
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis3 Μαρτίου 2024
Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria2 Φεβρουαρίου 2024